2) Endocrinology and Diabetology Service – Corbetta, Sabrina


Verdelli C, Avagliano L, Guarnieri V et al. Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors. Lab Invest 2017 doi:0.1038/labinvest.2017.88.


Mantovani G, Elli F, Corbetta S. Hypothyroidism associated with parathyroid disorders. Best Pract Res Clin Endocrinol Metab 2017; 31: 161-173.


Guarnieri V, Muscarella LA, Verdelli C, Corbetta S. Alterations of DNA methylation in parathyroid tumors. Mol Cell Endocrinol 2017 doi: 10.1016/j.mce.2017.05.010


Mingione A, Verdelli C, Ferrero S et al. Filamin A is reduced and contributes to the CASR sensitivity in human parathyroid tumors. J Mol Endocrinol 2017; 58: 91-103.


Marcocci C, Brandi ML, Scillitani A et al. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

J Endocrinol Invest 2015; 38: 577-593.


Verdelli C, Avagliano L, Creo P et al. Tumour-associated fibroblasts contribute to neoangiogenesis in human parathyroid neoplasia. Endocr Relat Cancer 2015; 22: 87-98.


Corbetta S, Vaira V, Guarnieri V et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocrine-Related Cancer 2010; 17: 1-13.

Corbetta S, Belicchi M, Pisati F et al. Expression of parathyroid specific genes in vascular endothelial progenitors of normal and tumoral parathyroids. Am J Pathol 2009; 175: 1200-1207.

Corbetta S, Eller-Vainicher C, Frigerio M et al. Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl–oxalate transporter in patients with primary hyperparathyroidism. Eur J Endocrinol 2009; 160: 283-288.


Corbetta S, Eller-Vainicher C, Vicentini L et al. Modulation of cyclin D1 expression in human tumoral parathyroid cells: effects of growth factors and calcium sensing receptor activation. Cancer Letters 2007; 255: 34-41.